$58.52
-0.88-1.48%
In chiusura: Nov 18, 4:00 PM EST
$58.52
N/A
Post-mercato: 4:05 PM EST

Vaxcyte (PCVX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-1.99 | $-2.06 | 3.40 % |
| Q2 | Aug 5, 2026 | $-1.97 | $-1.97 | 0.00 % |
| Q1 | May 6, 2026 | $-2.30 | $-1.79 | -28.5 % |
| Q4 | Feb 24, 2026 | $-1.80 | $-1.49 | -20.8 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0 | $12.50M | -100.0 % |
| Q1 | May 6, 2026 | $0 | $12.50M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.06 | $-1.97 | $-1.79 | $-1.49 |
| Actual | $-1.99 | $-1.97 | $-2.30 | $-1.80 |
| Surprise | +3.40% | 0.00% | -28.5% | -20.8% |
| Revenue | ||||
| Estimate | — | $12.5M | $12.5M | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.94 | $-1.66 |
| Revenue | ||
| Consensus | — | — |